Outpatient antimicrobial stewardship programs in pediatric institutions in 2020: Status, needs, barriers

Rana E El Feghaly1,2, Elizabeth A Monsees1,2, Alaina Burns2,3

  • 1Division of Infectious Diseases, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.

Insights

Pediatric outpatient antimicrobial stewardship programs (ASP) lack dedicated time and funding, hindering antibiotic stewardship efforts. Increased administrative support and resources are crucial for developing sustainable outpatient ASP infrastructure.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Public health

Background:

  • Pediatric outpatient antimicrobial stewardship programs (ASP) are critical for combating antibiotic resistance.
  • Many institutions have robust inpatient ASPs but lack developed outpatient programs.

Purpose of the Study:

  • To evaluate the current state of pediatric outpatient ASPs.
  • To identify resources, interventions, and barriers in pediatric outpatient ASPs.

Main Methods:

  • A cross-sectional study using an investigator-developed online survey.
  • Survey deployed to leaders of institutions in the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient (SHARPS-OP) collaborative.
  • Assessed institutional information, outpatient ASP status, interventions, and collaborative goals.

Main Results:

  • Only 11% of participating institutions had dedicated financial support for outpatient ASPs, compared to 95.6% for inpatient ASPs.
  • Common interventions included antimicrobial guidance, education, and quality improvement projects.
  • Lack of time (91.1%) and financial support (53.3%) were the primary barriers to expanding outpatient ASPs.

Conclusions:

  • Pediatric institutions significantly underinvest in outpatient ASPs compared to inpatient ASPs.
  • Administrative leaders must provide dedicated time and financial support to build sustainable outpatient stewardship infrastructure.
  • Collaborative efforts are needed to develop clear metrics and learning opportunities for pediatric outpatient ASP benchmarking.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
33
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
28
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
451
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34